Woodline Partners LP Arcturus Therapeutics Holdings Inc. Transaction History
Woodline Partners LP
- $19.5 Billion
- Q3 2025
A detailed history of Woodline Partners LP transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Woodline Partners LP holds 66,577 shares of ARCT stock, worth $484,014. This represents 0.01% of its overall portfolio holdings.
Number of Shares
66,577
Previous 780,442
91.47%
Holding current value
$484,014
Previous $10.2 Million
87.91%
% of portfolio
0.01%
Previous 0.06%
Shares
15 transactions
Others Institutions Holding ARCT
# of Institutions
173Shares Held
26MCall Options Held
2.32MPut Options Held
866K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$34.1 Million0.16% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$19.3 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.1.95MShares$14.2 Million0.39% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.95MShares$14.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$13.7 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $193M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...